Harrow Stock

Harrow P/B

The P/B (Price-to-Book Ratio) of Harrow (HROW) as of Aug 6, 2026 is 24.43. In the previous year, P/B (Price-to-Book Ratio) was 18.39 — a change of 32.81% (higher).

P/B

24.43

YoY

32.81%

Last updated:

P/B (Price-to-Book Ratio) of Harrow is 2026 24.43 . P/B (Price-to-Book Ratio) of Harrow was 2025 18.39 . It decreases by 32.81% higher compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

P/B (Price-to-Book Ratio) of Harrow is 24.43 in 2026.

P/B (Price-to-Book Ratio) of Harrow changed from 18.39 to 24.43, representing a 32.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Harrow since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Harrow with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Harrow

All Key Metrics — Harrow